Novo Nordisk A/S (NVON)

Mexico
Currency in MXN
1,779.300
+3.300(+0.19%)
Closed
NVON Scorecard
Full Analysis
Has raised its dividend for 7 consecutive years
Fair Value
Day's Range
1,779.0001,803.000
52 wk Range
1,623.0002,764.090
Key Statistics
Edit
Bid/Ask
1,770.50 / 1,795.00
Prev. Close
1,776
Open
1,791.1
Day's Range
1,779-1,803
52 wk Range
1,623-2,764.09
Volume
4.84K
Average Volume (3m)
2.84K
1-Year Change
-12.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NVON Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period
Show more

Novo Nordisk A/S Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Employees
76826
Market
Mexico

Compare NVON to Peers and Sector

Metrics to compare
NVON
Peers
Sector
Relationship
P/E Ratio
29.0x18.7x−0.6x
PEG Ratio
1.260.030.00
Price/Book
22.8x3.3x2.6x
Price / LTM Sales
10.2x2.9x3.1x
Upside (Analyst Target)
-7.6%48.8%
Fair Value Upside
Unlock11.8%7.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 22.67
Dividend Yield
1.01%
Industry Median 2.05%
Annualised payout
17.8768
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

167.47
ARM
-3.34%
13.290
RGTI
-3.90%
41.27
IONQ
-2.48%
169.88
VST
-1.01%
739.13
ASML
-0.47%

FAQ

What Is the Novo Nordisk ADR (NVON) Premarket Price Today?

The Novo Nordisk ADR (NVON) premarket price is . Premarket price change units: . Premarket percentage change: . Premarket volume: . Current date: 07 Feb 2025. Previous close: 1,776.00

What Stock Exchange Does Novo Nordisk ADR Trade On?

Novo Nordisk ADR is listed and trades on the Mexico stock exchange.

What Is the Stock Symbol for Novo Nordisk ADR?

The stock symbol for Novo Nordisk ADR is "NVON."

What Is the Novo Nordisk ADR (NVON) Afterhours Price Today? (Afterhours variable test: ) Current Date: 07 Feb 2025

After hours price: . After hours price change (units): . Price change percentage:

What Is the Novo Nordisk ADR Market Cap?

As of today, Novo Nordisk ADR market cap is 8.02T.

What is Novo Nordisk ADR Earnings Per Share?

The Novo Nordisk ADR EPS is 22.67.

From a Technical Analysis Perspective, Is NVON a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.